Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Pathways

Background:

• Medulloblastoma, a pediatric brain tumor, has poor outcomes upon relapse.
• Integrin-αvβ3 expression was previously linked to radioresistance in medulloblastoma cells.
• Ferroptosis, a regulated cell death, is induced by reactive oxygen species (ROS) and inhibited by antioxidants.

Purpose of the Study:

• To investigate the relationship between integrin-αvβ3 expression, ferroptosis inhibition, and medulloblastoma sensitivity to radiotherapy.
• To elucidate the role of integrin-αvβ3 signaling in oxidative stress resilience and cell death mechanisms.

Main Methods:

• Utilized β3-subunit knockout (β3_KO) medulloblastoma cell models.
• Assessed lipid hydroxyperoxide accumulation post-radiotherapy to indicate ferroptosis.
• Correlated β3-subunit expression with radiotherapy sensitivity and levels of anti-ferroptotic proteins.

Main Results:

• Irradiated β3_KO medulloblastoma cells predominantly underwent ferroptosis.
• β3-subunit expression positively correlated with radiotherapy sensitivity.
• Integrin-αvβ3 signaling appears to enhance oxidative stress resilience through mTORC1 activation.

Conclusions:

• Integrin-αvβ3 expression is associated with resistance to ferroptosis in medulloblastoma.
• Targeting integrin-αvβ3 may represent a novel strategy to enhance radiotherapy efficacy.
• Inducing ferroptotic cell death via integrin-αvβ3 inhibition could improve treatment outcomes for medulloblastoma.